ADC Therapeutics (ADCT) Gross Margin (2021 - 2026)
ADC Therapeutics' Gross Margin came in at 87.80% for Q2 2026, down 7.77 percentage points from 95.56% a year earlier but up 5.13 percentage points from the prior quarter.
Powered by 
Analysis
ADC Therapeutics (ADCT) Gross Margin (2021 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, ADC Therapeutics reported Gross Margin of 89.38%, down 4.23 percentage points year-over-year.
- The five-year range for quarterly Gross Margin is 82.66% (Q1 2026) to 98.86% (Q1 2022).
- Year-over-year, Gross Margin increased in two of the last six quarters, with an average year-over-year change of -2.42 percentage points.
- The fastest year-over-year change in Gross Margin over five years came in Q2 2023 (a gain of 7.23 percentage points), and the weakest in Q1 2024 (a drop of 10.80 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.82 Bn | 1,105.41 Bn | 19.71 Bn | 85.78% |
| 2 | Johnson & Johnson | 617.41 Bn | 535.94 Bn | 17.26 Bn | 68.19% |
| 3 | AbbVie | 501.29 Bn | 474.40 Bn | 12.70 Bn | 74.74% |
| 4 | Merck | 368.15 Bn | 322.53 Bn | 12.21 Bn | 73.54% |
| 5 | Novartis Ag | 297.07 Bn | 261.06 Bn | 11.24 Bn | 78.02% |
| 6 | Astrazeneca | 260.90 Bn | 234.58 Bn | 12.86 Bn | 83.60% |
| 7 | Amgen | 236.34 Bn | 191.74 Bn | 7.24 Bn | 72.04% |
| 8 | Gilead Sciences | 191.00 Bn | 165.20 Bn | 6.22 Bn | 79.76% |
| 9 | Pfizer | 169.72 Bn | 116.36 Bn | 10.94 Bn | 72.78% |
| 10 | ADC Therapeutics | 233.30 Mn | -712.89 Mn | 16.90 Mn | 87.80% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 87.80% |
| Mar 31, 2026 | 82.66% |
| Sep 30, 2025 | 92.68% |
| Jun 30, 2025 | 95.56% |
| Mar 31, 2025 | 91.05% |
| Sep 30, 2024 | 95.39% |
| Jun 30, 2024 | 93.01% |
| Mar 31, 2024 | 86.10% |
| Sep 30, 2023 | 98.56% |
| Jun 30, 2023 | 94.13% |
| Mar 31, 2023 | 96.89% |
| Sep 30, 2022 | 98.30% |
| Jun 30, 2022 | 86.89% |
| Mar 31, 2022 | 98.86% |
| Sep 30, 2021 | 96.18% |
| Jun 30, 2021 | 96.78% |
API Access
ADC Therapeutics Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=ADCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "ADCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=ADCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();